pubmed-article:11843691 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0020443 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0074554 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0001721 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C1156530 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
pubmed-article:11843691 | lifeskim:mentions | umls-concept:C0208133 | lld:lifeskim |
pubmed-article:11843691 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:11843691 | pubmed:dateCreated | 2002-2-14 | lld:pubmed |
pubmed-article:11843691 | pubmed:abstractText | Previous studies have shown that patients with early onset of Alzheimer disease and vascular dementia have higher levels of circulating brain-derived 24S-hydroxycholesterol (cerebrosterol). Two recent epidemiological studies indicated that treatment with inhibitors of cholesterol synthesis (statins) reduces the incidence of Alzheimer disease. | lld:pubmed |
pubmed-article:11843691 | pubmed:language | eng | lld:pubmed |
pubmed-article:11843691 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11843691 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11843691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11843691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11843691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11843691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11843691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11843691 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11843691 | pubmed:month | Feb | lld:pubmed |
pubmed-article:11843691 | pubmed:issn | 0003-9942 | lld:pubmed |
pubmed-article:11843691 | pubmed:author | pubmed-author:OttoCarstenC | lld:pubmed |
pubmed-article:11843691 | pubmed:author | pubmed-author:LocatelliSand... | lld:pubmed |
pubmed-article:11843691 | pubmed:author | pubmed-author:LütjohannDiet... | lld:pubmed |
pubmed-article:11843691 | pubmed:author | pubmed-author:SchmidtHartmu... | lld:pubmed |
pubmed-article:11843691 | pubmed:author | pubmed-author:BeisiegelUlri... | lld:pubmed |
pubmed-article:11843691 | pubmed:author | pubmed-author:von... | lld:pubmed |
pubmed-article:11843691 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11843691 | pubmed:volume | 59 | lld:pubmed |
pubmed-article:11843691 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11843691 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11843691 | pubmed:pagination | 213-6 | lld:pubmed |
pubmed-article:11843691 | pubmed:dateRevised | 2009-11-3 | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:meshHeading | pubmed-meshheading:11843691... | lld:pubmed |
pubmed-article:11843691 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:11843691 | pubmed:articleTitle | Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. | lld:pubmed |
pubmed-article:11843691 | pubmed:affiliation | Department of Clinical Pharmacology, Universitätsklinikum, University of Bonn, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany. | lld:pubmed |
pubmed-article:11843691 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11843691 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:11843691 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11843691 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11843691 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11843691 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11843691 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11843691 | lld:pubmed |